Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "amarillo"


25 mentions found


"I found cash budgeting and I literally stuck to it," Taylor says. Posts of her managing her finances by stuffing cash into envelopes soon went viral. When Taylor began cash stuffing, she operated on a zero-based budget, which is the most common option among cash stuffers, she says. Jasmine Taylor uses cash stuffing to budget her income. Second, she realized there was a market for people like her who found cash stuffing attractive but found plain, old envelopes drab.
Of the various potential rulings possible in the case involving the abortion pill mifepristone, either of those outcomes would be unprecedented judicial intervention in the agency's regulatory process. Some of the FDA's options could be politically and legally risky both for the agency and mifepristone suppliers, they said. The FDA said the pill was deemed safe after extensive studies and use, and that the challenge comes much too late. Under FDA statutes and regulations, drug approval withdrawal generally begins with an informal hearing, which can entail extensive document preparation and the convening of an advisory committee. Overseas provider Aid Access, an Austria-based service that ships abortion medication to U.S. patients, said it would continue providing the pill no matter how the FDA responds.
Abortion rights advocates gather in front of the J Marvin Jones Federal Building and Courthouse in Amarillo, Texas, on March 15, 2023. Judge Matthew Kacsmaryk of the U.S. Northern District of Texas in Amarillo heard four hours of arguments. The anti-abortion group that filed the lawsuit, the Alliance Defending Freedom, presented their case against the FDA first. They were followed by Justice Department attorneys defending the FDA and then the abortion pill maker Danco Laboratories. The Alliance Defending Freedom argued that mifepristone is unsafe and the FDA did not properly follow its approval process when it cleared mifepristone for use in 2000.
The Alliance For Hippocratic Medicine wants Judge Kacsmaryk to nullify the FDA's medical approval of mifepristone, which would effectively ban the abortion pill across the US. Senate Judiciary Committee | YouTubeA Texas judge will soon issue a pivotal ruling in a closely watched case challenging the Food and Drug Administration's approval of the abortion pill mifepristone. It's also possible that Kacsmaryk could order the agency to impose tighter restrictions on access to mifepristone but stop short of completely halting sales. Abortion rights groups and legal experts expect the judge will rule against the FDA in some form. Possible injunctionIf Kacsmaryk issues an order to withdraw mifepristone from the market, there are several ways such a ruling could be drafted.
AMARILLO, Texas—A federal judge is set to hear arguments Wednesday on whether to block sales of a medication used in more than half of the abortions in the U.S., the first public hearing in a case that has drawn national attention. Antiabortion medical groups and individual physicians filed a lawsuit in November, arguing that the Food and Drug Administration exceeded its authority when it approved the sale of the abortion-inducing pill known as mifepristone under a process meant for treatments of serious or life-threatening illnesses. The judge is now weighing whether to issue a preliminary injunction blocking sales of the pill while litigation continues.
March 15 (Reuters) - A U.S. judge in Texas is set to hear arguments on Wednesday in a bid by anti-abortion groups to ban sales of the abortion pill mifepristone across the country, even in states where abortion is legal, as they challenge regulatory approval granted more than two decades ago. Twelve of the 50 states now ban abortion outright while some others prohibit it after a certain length of pregnancy, according to the Guttmacher Institute, a research organization that supports abortion rights. The judge cited death threats and harassment directed at the court during the case and a wish to avoid disruption. After appealing to the 5th Circuit, the losing side could seek to take the matter to the U.S. Supreme Court. Reporting by Brendan Pierson in New York; Editing by Will Dunham and Alexia GaramfalviOur Standards: The Thomson Reuters Trust Principles.
The Alliance For Hippocratic Medicine wants Judge Kacsmaryk to nullify the FDA's medical approval of mifepristone, which would effectively ban the abortion pill across the US. But Kacsmaryk asked the attorneys to not to publicize the hearing, citing security concerns. Those present at the Friday conference call included lawyers from the Justice Department, the abortion pill maker Danco Laboratories, and a group that opposes abortion called the Alliance Defending Freedom. A group of physicians who oppose abortion called the Alliance for Hippocratic Medicine asked Kacsmaryk in November to order the Food and Drug Administration to withdraw its approval of the abortion pill mifepristone. The abortion pill has become the central flashpoint in the legal battle over access to abortion in the wake of the Supreme Court's ruling that overturned Roe v. Wade last June.
A federal judge in Texas publicly disclosed that he scheduled a hearing in a case seeking to overturn the Food and Drug Administration's approval of the abortion pill mifepristone, after media outlets criticized him for attempting to keep the proceedings secret until the last minute. The hearing will take place in Amarillo, Texas. Media outlets filed a letter on Monday urging Kacsmaryk to disclose the date of the hearing immediately. The outlets included NBCUniversal News Group, of which CNBC is a part, The Washington Post, ProPublica, the Texas Press Association and Gannett, among others. They argued that the way the FDA approved mifepristone violated federal law.
Judge Matthew Kacsmaryk is overseeing a lawsuit that challenges the FDA approval of mifepristone. A hearing was scheduled for Wednesday, but the judge hoped to delay publicizing the date, per WaPo. But the Texas judge overseeing the case — who is known for his conservative politics and anti-abortion stance — hoped to hide the date of the hearing until right before the scheduled date, The Washington Post reported. In addition, he told attorneys on the call that members of the courthouse have received threats due to the lawsuit, the Post reported. According to the report, the Post had attempted to seek information about the date of the hearing before the Friday call but received no response.
In 2020, while working as a staff nurse at a hospital in Spartanburg, South Carolina, Aspen Tucker came across a job posting for a travel nurse. In 2020, Aspen Tucker left his staff nursing job to become a travel nurse, a move that came with a significant bump in pay. "I'm able to have a high salary as a travel nurse, but also come back to where the cost of living is low," he says. That month he split an Airbnb with his girlfriend (also a travel nurse who occasionally takes jobs at the same hospitals) in addition to paying his mortgage and utilities back home. When he's traveling work, Tucker pays friends and family to take care of his dog, Skye.
After languishing on the market for years, late oil tycoon T. Boone Pickens' massive Texas ranch has finally found a buyer. Mesa Vista RanchIn 2017, the late oil magnate listed his ranch in the Texas Panhandle, northeast of Amarillo, for $250 million. Five years later, the estate was sold — but for $60 million less than its listed price. But on January 14, 2020, the property received a $30 million price cut, reported Mansion Global. In late November, Pickens' estate finally sold, but at a further reduced price, Jay Rosser, a longtime representative for Pickens, told Insider.
The U.S. Department of Labor rule, which took effect Jan. 30, lifts barriers to ESG investing imposed by the Trump administration. The new rule sets guidelines for ESG investing, including requiring that socially conscious investments are still financially sound. They claim that allowing ESG investing will jeopardize the retirement savings of millions of people and lower state tax revenue. The Biden administration rule has divided the business community. The U.S. Securities and Exchange Commission (SEC) has proposed various rules aimed at increasing transparency related to ESG investing.
Matthew Kacsmaryk is a Texas federal judge who was nominated by Donald Trump in 2017. Kacsmaryk graduated from Abilene Christian University in 1999 and received his law degree from the University of Texas School of Law in 2003. The Post reported that it was during law school when Kacsmaryk focused on abortion rights. Kacsmaryk also served as the executive editor of the Texas Review of Law & Politics and received two Dean's Achievement Awards, according to the questionnaire. During his undergraduate years, studying political science, Kacsmaryk was outspoken about his conservative views and stances on abortion.
Companies Liberty Energy Inc FollowFeb 22 (Reuters) - A coalition of Republican-led states has asked a federal judge to block a Biden administration rule allowing retirement plans to consider environmental, social and corporate governance (ESG) factors in selecting investments pending the outcome of their legal challenge. The 25 states in a motion filed in Amarillo, Texas federal court on Tuesday said the rule, which took effect Jan. 30, could lead to millions of Americans losing retirement investments and harm states' finances. The Biden administration has moved to transfer the lawsuit to a different court, accusing the states of engaging in judge shopping. An appointee of Republican former President Donald Trump, Kacsmaryk has previously struck down Biden administration rules on immigration and healthcare protections for LGBTQ people. The ESG rule makes it easier for retirement plans to invest in socially-responsible funds and companies, though it also requires traditional financial considerations.
Feb 21 (Reuters) - A Texas federal judge on Tuesday refused to set an accelerated trial schedule for a lawsuit by anti-abortion groups seeking to end U.S. sales of the abortion pill mifepristone, in a case that could severely disrupt access to medication abortion nationwide. Mifepristone is approved for medication abortion in the first 10 weeks of pregnancy in combination with another drug, misoprostol. Medication abortion accounts for more than half of U.S. abortions. Medication abortion has drawn increasing attention since the U.S. Supreme Court last year reversed its landmark 1973 Roe v. Wade ruling, which had guaranteed abortion rights nationwide. President Joe Biden, a Democrat, directed federal agencies to expand access to medication abortion in response to the decision, which has allowed more than a dozen Republican-led states to adopt new abortion bans.
Banning mifepristone will result in more women dying in pregnancy, Democratic attorneys general argued this month. The argument comes as a judge in Texas is considering a ban on the abortion pill. Republican attorneys general who have weighed in on the case also maintain that its approval infringed on state rights. In her brief, James noted that carrying a pregnancy to term poses significantly greater health risks than an early abortion. As Slate's Christina Cautertucci notes, mifepristone is only one of the two drugs used in a typical medication abortion.
In one, generic mifepristone maker GenBioPro is asking a federal judge to block West Virginia, which has a near-total abortion ban, from prohibiting sales of the pills. The state is one of 16 that allow abortion under some circumstances, but impose additional restrictions on mifepristone that make it harder to access. WHAT WOULD HAPPEN IF THE TEXAS PLAINTIFFS WIN? IS A WIN BY TEXAS PLAINTIFFS LIKELY? The West Virginia lawsuit makes a more novel legal argument, since West Virginia's abortion ban applies to all abortions and does not specifically regulate mifepristone.
Medication abortion has drawn increasing attention since the U.S. Supreme Court last year reversed its landmark 1973 Roe v. Wade ruling, which had guaranteed abortion rights nationwide. President Joe Biden, a Democrat, directed federal agencies to expand access to medication abortion in response to the decision. Mifepristone is used in combination with another drug, misoprostol, for medication abortion, which accounts for more than half of U.S. abortions. They said ending access to the drug would force patients to have unnecessary surgical abortions or prevent them from accessing abortion altogether. The Texas lawsuit could move quickly, as the plaintiffs in a filing on Friday asked Kacsmaryk to skip a hearing on a preliminary order and instead go straight to trial.
"It's judge shopping on steroids," said Sarah Lipton-Lubet, executive director of the progressive legal advocacy group Take Back the Court. The Biden administration has called the lawsuit "unprecedented" and urged Kacsmaryk to not deprive women of a long-approved safe and effective drug. At least eight have led to rulings blocking Biden policies, with several more pending. The chief judges of Texas federal courts have the authority to reallocate cases to other judges, but have largely not done so, he said. Absent a change, litigants have every right to take advantage of that structure to seek a favorable judge, he said.
The states filed a complaint in a federal court in Amarillo, Texas, on Thursday arguing that the rule finalized in November will lead many retirement plans to focus on a social agenda rather than long-term financial stability for investors. The rule, which takes effect on Monday, reverses restrictions on socially conscious investing that were adopted by the Trump administration. The states in Thursday's lawsuit said the new rule fails to justify the departure from Trump-era regulations, in violation of the federal law governing rulemaking. And, the states said, it violates the U.S. law that regulates employee benefit plans by failing to protect retirement assets. The case is Utah v. Walsh, U.S. District Court for the Northern District of Texas, No.
Medication abortion has drawn increasing attention since the U.S. Supreme Court last June overturned its landmark 1973 Roe v. Wade decision that had legalized abortion nationwide. Nearly all abortions, including medication abortions, are now banned in 12 states, and 16 states that permit some abortions also had laws restricting medication abortion as of November, according to the Guttmacher Institute, a research group that supports abortion rights. "The FDA, by approving chemical abortion drugs for home use, puts a woman or girl's life at risk." In its court filing, the FDA said there was no basis for second-guessing the FDA's judgment. The FDA said that pulling the drug would force patients seeking abortions in many cases to undergo unnecessary and more invasive surgical abortion.
VATICAN CITY — The Vatican has defrocked an anti-abortion U.S. priest, Frank Pavone, for what it said were “blasphemous communications on social media” as well as “persistent disobedience” of his bishop who repeatedly told him to stop his partisan activism for Donald Trump. Even before then, Pavone successfully appealed 2011 restrictions on his ministry that Amarillo Bishop Patrick Zurek had placed on him. Pavone remained a firm supporter of Trump and in 2020 disputed the outcome of the election won by Joe Biden. Ahead of the election, the Amarillo diocese denounced Pavone’s use of social media for political ends, distanced the diocese from him and said his positions weren’t consistent with Catholic teaching. The statement said Pavone was given “ample opportunity to defend himself” as well as to submit to his bishop.
A new abortion battle is moving to the courts, this time over a pill for ending pregnancies. Abortion opponents sued the Food and Drug Administration and Health and Human Services department in federal court in Amarillo, Texas, on Friday, seeking to undo the approval of the abortion-inducing pill called mifepristone as well as subsequent agency decisions easing access to the drug.
Nov 11 (Reuters) - A federal judge in Texas ruled on Friday that President Joe Biden's administration had wrongly interpreted an Obamacare provision as barring health care providers from discriminating against gay and transgender people. U.S. District Judge Matthew Kacsmaryk in Amarillo ruled that a landmark U.S. Supreme Court decision in 2020 holding that a law barring workplace discrimination protects gay and transgender employees did not apply to the healthcare law. "Title IX's ordinary public meaning remains intact until changed by Congress, or perhaps the Supreme Court," Kacsmaryk wrote. The Obama administration introduced rules in 2016 that made clear that LGBT people would be protected under the healthcare discrimination provision. In June, the Biden administration proposed a rule to once again enshrine such protections.
Viral TikTok shows bison charge woman in Texas park
  + stars: | 2022-10-18 | by ( Julianne Mcshane | ) www.nbcnews.com   time to read: +3 min
A Texas hiker is warning other outdoor enthusiasts to beware of bison through a viral TikTok video that shows one charging her on a trail, sending her to the hospital with non-life-threatening injuries. Clark, the Texas Park and Wildlife Department, and United Regional Wichita Falls, the hospital where Clark said she received treatment, did not immediately respond to requests for comment. Once nearly extinct, bison now number half a million, with most part of private herds, according to the Texas Park and Wildlife Department. Caprock Canyons State Park is the home of the Texas State Bison Herd, which is monitored by park officials, according to the department. "As a rule, bison require at least 50 yards (half a football field) between them and people," the Texas Park and Wildlife Department said.
Total: 25